Article
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.
Pathology - 1 Jan 2016
Clay T D, Russell P A, Do H, Sundararajan V, Conron M, Wright G M, Dobrovic A, Moore M M, McLachlan S A
Abstract excerpt
We sought to investigate the frequency of mutations in epidermal growth factor receptor (EGFR) and Kirsten-RAS (KRAS) by each pathological subtype for patients with resected pulmonary adenocarcinoma as defined by the IASLC/ATS/ERS classification. Histological examination determined the predominant subtype according to the IASLC/ATS/ERS classification. EGFR and KRAS mutations were determined by high-resolution...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.